Histone acetylase activity (HAT) of CBP/p300 is believed to be important for their function in transcriptional activation. However, it is not clear what are the real substrates of acetylation by CBP/p300 in vivo, and whether the HAT activity of CBP/p300 is essential for development and tumor suppressor function. To address these issues, I will make a mouse model that expresses a CBP mutant deficient in HAT function (CBP-hat). The phenotypes of heterozygous and homozygous CBP-hat animals will be compared to that of the CBP heterozygous and nullizygous animals to characterize the physiological significance of the HAT function of CBP.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32DK061907-01
Application #
6445793
Study Section
Special Emphasis Panel (ZRG1-SSS-N (20))
Program Officer
Bishop, Terry Rogers
Project Start
2002-04-01
Project End
Budget Start
2002-04-01
Budget End
2003-03-31
Support Year
1
Fiscal Year
2002
Total Cost
$46,192
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02215